logo

Lunsumio Subcutaneous Injection 5mg and another item

Closed · Japan

Source: Japan External Trade Organization (JETRO)

Tender
Closed

Classification of the service to be procured : Nature and quantity of the services to be required : Lunsumio Subcutaneous Injection 5mg and another item Expected date of the contract award : April 30, 202 Reasons for the use single tendering procedures as provided for in the Agreement on Government Procurement : b "Protection of Exclusive Rights" Contact point for in the notice : Hiroyuki Inoue,

Status
Closed
Sector
Government, Hospital
Location
Japan
Updated
3 Nov 2026
Source
Japan External Trade Organization (JETRO)

ConstructChat

Ask ConstructChat about Lunsumio Subcutaneous Injection 5mg and another item

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Lunsumio Subcutaneous Injection 5mg and another item” is a tender record in Taiyo, linked to the Government sector. It is issued for works, goods, or services related to Japan.

Participants

Not available for this record.

Status

Original status

closed

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

Classification of the service to be procured : Nature and quantity of the services to be required : Lunsumio Subcutaneous Injection 5mg and another item Expected date of the contract award : April 30, 202 Reasons for the use single tendering procedures as provided for in the Agreement on Government Procurement : b "Protection of Exclusive Rights" Contact point for in the notice : Hiroyuki Inoue, Planning section manager of Kyushu Medical Center, 1-8- Jigyohama, Chuo-ku, Fukuoka Prefecture 810-856 Japan. TEL 092-852-0700

Location

Country

Japan

Source

Source

Japan External Trade Organization (JETRO)

URL

More Details

Record type

Tender

Sector

Government, Hospital

Article published date

2026-07-03

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender